(3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid

C33H40N6O6S — CID 146399578

IUPAC(3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid
SMILESCCn1nnc2c(C)c([C@@H](c3cnc(C)c(CN4CC5(CCOCC5)Oc5ncc(C)cc5S4(=O)=O)c3)C(C)(C)C(=O)O)ccc21
InChIInChI=1S/C33H40N6O6S/c1-7-39-26-9-8-25(21(3)29(26)36-37-39)28(32(5,6)31(40)41)23-15-24(22(4)34-17-23)18-38-19-33(10-12-44-13-11-33)45-30-27(46(38,42)43)14-20(2)16-35-30/h8-9,14-17,28H,7,10-13,18-19H2,1-6H3,(H,40,41)/t28-/m1/s1
InChIKeyODFKKRFIOFOAHR-MUUNZHRXSA-N
MW648.79 g/mol
LogP4.54
Rot. Bonds7

About (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid

(3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid (PubChem CID 146399578) has the molecular formula C33H40N6O6S and a molecular weight of 648.79 g/mol. Its IUPAC name is (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid.

Molecular Properties

Compound Name(3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid
PubChem CID146399578
Molecular FormulaC33H40N6O6S
Molecular Weight648.79 g/mol
Exact Mass648.27
IUPAC Name(3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid
SMILESCCn1nnc2c(C)c([C@@H](c3cnc(C)c(CN4CC5(CCOCC5)Oc5ncc(C)cc5S4(=O)=O)c3)C(C)(C)C(=O)O)ccc21
InChIInChI=1S/C33H40N6O6S/c1-7-39-26-9-8-25(21(3)29(26)36-37-39)28(32(5,6)31(40)41)23-15-24(22(4)34-17-23)18-38-19-33(10-12-44-13-11-33)45-30-27(46(38,42)43)14-20(2)16-35-30/h8-9,14-17,28H,7,10-13,18-19H2,1-6H3,(H,40,41)/t28-/m1/s1
InChIKeyODFKKRFIOFOAHR-MUUNZHRXSA-N
XLogP4.54
TPSA149.63 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500648.79
LogP ≤ 54.54
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Analyze (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid?
The IUPAC name of (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid (CID 146399578) is (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid.
What is the SMILES notation for (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid?
The canonical SMILES for (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid is CCn1nnc2c(C)c([C@@H](c3cnc(C)c(CN4CC5(CCOCC5)Oc5ncc(C)cc5S4(=O)=O)c3)C(C)(C)C(=O)O)ccc21.
What is the InChIKey of (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid?
The InChIKey is ODFKKRFIOFOAHR-MUUNZHRXSA-N. The full InChI is InChI=1S/C33H40N6O6S/c1-7-39-26-9-8-25(21(3)29(26)36-37-39)28(32(5,6)31(40)41)23-15-24(22(4)34-17-23)18-38-19-33(10-12-44-13-11-33)45-30-27(46(38,42)43)14-20(2)16-35-30/h8-9,14-17,28H,7,10-13,18-19H2,1-6H3,(H,40,41)/t28-/m1/s1.
What are the key properties of (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid?
(3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid has a molecular weight of 648.79 g/mol, XLogP of 4.54, 7 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethyl-3-[6-methyl-5-[(8-methyl-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl)methyl]-3-pyridinyl]propanoic acid is sourced from PubChem (CID 146399578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).